Xuehang Jin

415 total citations
10 papers, 244 citations indexed

About

Xuehang Jin is a scholar working on Molecular Biology, Infectious Diseases and Cancer Research. According to data from OpenAlex, Xuehang Jin has authored 10 papers receiving a total of 244 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Infectious Diseases and 3 papers in Cancer Research. Recurrent topics in Xuehang Jin's work include RNA modifications and cancer (2 papers), Metal-Catalyzed Oxygenation Mechanisms (2 papers) and Cancer-related molecular mechanisms research (2 papers). Xuehang Jin is often cited by papers focused on RNA modifications and cancer (2 papers), Metal-Catalyzed Oxygenation Mechanisms (2 papers) and Cancer-related molecular mechanisms research (2 papers). Xuehang Jin collaborates with scholars based in China and United States. Xuehang Jin's co-authors include Yunqing Qiu, Lushun Jiang, Zhe Wu, Li Wang, Xiaolan Xu, Li Wang, Zhe Wu, Li Zhang, Yan Lou and Wei Yu and has published in prestigious journals such as Medicine, Biomedicine & Pharmacotherapy and Diagnostic Microbiology and Infectious Disease.

In The Last Decade

Xuehang Jin

9 papers receiving 235 citations

Peers

Xuehang Jin
Xuehang Jin
Citations per year, relative to Xuehang Jin Xuehang Jin (= 1×) peers Lushun Jiang

Countries citing papers authored by Xuehang Jin

Since Specialization
Citations

This map shows the geographic impact of Xuehang Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuehang Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuehang Jin more than expected).

Fields of papers citing papers by Xuehang Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuehang Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuehang Jin. The network helps show where Xuehang Jin may publish in the future.

Co-authorship network of co-authors of Xuehang Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Xuehang Jin. A scholar is included among the top collaborators of Xuehang Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuehang Jin. Xuehang Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
2.
Jin, Xuehang, et al.. (2024). Advances in diagnosis and treatment of non-tuberculous mycobacterial lung disease. Diagnostic Microbiology and Infectious Disease. 109(2). 116254–116254. 2 indexed citations
3.
Wang, Linying, et al.. (2024). Cryptogenic organizing pneumonia caused by solanine: A case report. Medicine. 103(39). e39807–e39807.
4.
Jin, Xuehang, et al.. (2023). Serum Ribonucleotide Reductase Subunit M2 in Patients with Chronic Liver Diseases and Hepatocellular Carcinoma. Laboratory Medicine. 54(6). 626–632. 2 indexed citations
5.
Xu, Hao, et al.. (2021). In vitro Antimicrobial Activity of Fosfomycin, Rifampin, Vancomycin, Daptomycin Alone and in Combination Against Vancomycin-Resistant Enterococci. Drug Design Development and Therapy. Volume 15. 3049–3055. 8 indexed citations
6.
Jiang, Lushun, Zhe Wu, Xiaolan Xu, et al.. (2021). Opportunities and challenges of artificial intelligence in the medical field: current application, emerging problems, and problem-solving strategies. Journal of International Medical Research. 49(3). 3619061085–3619061085. 104 indexed citations
7.
Jiang, Lushun, Xuehang Jin, Zhe Wu, et al.. (2020). Inhibiting RRM2 to enhance the anticancer activity of chemotherapy. Biomedicine & Pharmacotherapy. 133. 110996–110996. 89 indexed citations
9.
Wu, Zhe, Li Wang, Li Zhang, et al.. (2020). Identification of osalmid metabolic profile and active metabolites with anti-tumor activity in human hepatocellular carcinoma cells. Biomedicine & Pharmacotherapy. 130. 110556–110556. 11 indexed citations
10.
Jin, Xuehang, Changzhou Cai, & Yunqing Qiu. (2019). Diagnostic Value of Circulating microRNAs in Hepatitis B Virus-Related Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Journal of Cancer. 10(20). 4754–4764. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026